Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Efficacy, tolerability and cardioprotective properties of rilmenidine were examined in patients with mild to moderate arterial hypertension (AH). The trial involved 51 hypertensive subjects, mean age 57,7+2,5 years. After wash-out period, rilmenidine was administered in the daily dose of 1-2 mg. At...

Detaylı Bibliyografya
Asıl Yazarlar:	S. S. Yakushin, N. I. Ivankova, N. S. Sazonova, N. V. Vilesova, G. O. Ivanova
Materyal Türü:	Makale
Dil:	Russian
Baskı/Yayın Bilgisi:	«FIRMA «SILICEA» LLC 2004-12-01
Seri Bilgileri:	Российский кардиологический журнал
Konular:	arterial hypertension metabolic syndrome cardioprotective effects rilmenidine
Online Erişim:	https://russjcardiol.elpub.ru/jour/article/view/2326

Benzer Materyaller

EFFECT OF ANTIHYPERTENSIVE THERAPY WITH RILMENIDINE ON COGNITIVE FUNCTION IN ELDERLY HYPERTENSIVE PATIENTS
Yazar:: S. V. Nedogoda, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

ASSESSMENT OF RILMENIDINE EFFICIENCY IN PATIENTS WITH ARTERIAL HYPERTENSION WITH DETERIORATION OF DAILY PROFILE OF BLOOD PRESSURE
Yazar:: P. P. Tikhonov, ve diğerleri
Baskı/Yayın Bilgisi: (2015-12-01)

Perspectives of decreasing individual cardiovascular risk in high- and very high risk patients with arterial hypertension, treated with rilmenidine
Yazar:: S. V. Nedogoda, ve diğerleri
Baskı/Yayın Bilgisi: (2005-06-01)

Workplace arterial hypertension: potential of rilmenidine-based combination therapy
Yazar:: S. I. Drozdetsky, ve diğerleri
Baskı/Yayın Bilgisi: (1970-01-01)

Rilmenidine treatment in hypertensive patients with cerebrovascular transient ischemic attacks
Yazar:: A. P. Kondrakhin, ve diğerleri
Baskı/Yayın Bilgisi: (2005-10-01)

Rilmenidine therapy potential in pharmaceutical correction of endothelial dysfunction among women with arterial hypertension, Type 2 diabetes mellitus, and visceral obesity
Yazar:: E. V. Eliseeva, ve diğerleri
Baskı/Yayın Bilgisi: (1970-01-01)

THE WAYS OF SYMPATHETIC SYSTEM OVERACTIVITY BLOCKING: RILMENIDINE VERSUS ATENOLOL
Yazar:: Y. R. Kasherininov, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

Autophagy and anti-inflammation ameliorate diabetic neuropathy with Rilmenidine
Yazar:: Mehmet Burak Yalçın, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

Rilmenidine Protects Against Joint Damage in MIA-induced Model of Osteoarthritis in Rats
Yazar:: Osman Kukula, ve diğerleri
Baskı/Yayın Bilgisi: (2024-02-01)

Stimulation of mTOR-independent autophagy and mitophagy by rilmenidine exacerbates the phenotype of transgenic TDP-43 mice
Yazar:: Nirma D. Perera, ve diğerleri
Baskı/Yayın Bilgisi: (2021-07-01)

Main results of the Russian trial «ALTAIR»
Yazar:: E. V. Shlyakhto, ve diğerleri
Baskı/Yayın Bilgisi: (2006-02-01)

Comparison in conscious rabbits of the baroreceptor-heart rate reflex effects of chronic treatment with rilmenidine, moxonidine, and clonidine
Yazar:: Monique L Parkin, ve diğerleri
Baskı/Yayın Bilgisi: (2016-11-01)

ARTERIAL HYPERTENSION IN YOUNG PEOPLE: EFFICACY OF SYMPATHOLYTIC THERAPY
Yazar:: N. N. Nikitina, ve diğerleri
Baskı/Yayın Bilgisi: (2015-12-01)

Effects of centrally acting antihypertensive drugs on the microcirculation of spontaneously hypertensive rats
Yazar:: V. Estato, ve diğerleri
Baskı/Yayın Bilgisi: (2004-10-01)

PHARMACEUTICAL CORRECTION OF VASCULAR DISTURBANCES IN PATIENTS WITH ARTERIAL HYPERTENSION
Yazar:: L. A. Khaisheva, ve diğerleri
Baskı/Yayın Bilgisi: (2010-10-01)

Combined treatment of arterial hypertension: focus on calcium antagonist and ACE inhibitor combination
Yazar:: V. I. Makolkin
Baskı/Yayın Bilgisi: (2008-12-01)

Not first‐line antihypertensive agents, but still effective—The efficacy and safety of imidazoline receptor agonists: A network meta‐analysis
Yazar:: András Érszegi, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

Cerebral blood flow and blood rheology in hypertensive patients during rilmenidine treatment
Yazar:: L. I. Markova, ve diğerleri
Baskı/Yayın Bilgisi: (2004-06-01)

BISOPROLOL AND METFORMIN IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME
Yazar:: V. A. Nevzorova, ve diğerleri
Baskı/Yayın Bilgisi: (2015-12-01)

Prevalence of metabolic syndrome and its components in patients with arterial hypertension and obesity
Yazar:: I. E. Chazova, ve diğerleri
Baskı/Yayın Bilgisi: (2005-12-01)

Valsartan effects on platelet activity in patients with arterial hypertension and metabolic syndrom
Yazar:: I. N. Medvedev, ve diğerleri
Baskı/Yayın Bilgisi: (2007-06-01)

Reduced platelet aggregation in losartan-treated patients with arterial hypertension and metabolic syndrome
Yazar:: I. N. Medvedev, ve diğerleri
Baskı/Yayın Bilgisi: (2008-10-01)

Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome
Yazar:: I. N. Medvedev, ve diğerleri
Baskı/Yayın Bilgisi: (2008-02-01)

Intravascular platelet activity correction by fosinopril in arterial hypertension patients with metabolic syndrome
Yazar:: I. N. Medvedev, ve diğerleri
Baskı/Yayın Bilgisi: (2006-10-01)

Microcirculatory function in patients with arterial hypertension, metabolic syndrome and diabetes mellitus
Yazar:: A. P. Vasilyev, ve diğerleri
Baskı/Yayın Bilgisi: (2008-10-01)

Some hormonal systems in males with arterial hypertension and metabolic syndrome
Yazar:: A. N. Britov, ve diğerleri
Baskı/Yayın Bilgisi: (2006-06-01)

Metabolic syndrome in patients with arterial hypertension living in the Far North (on the example of the Khanty-Mansi Autonomous Okrug — Yugra)
Yazar:: E. G. Ivanova, ve diğerleri
Baskı/Yayın Bilgisi: (2023-04-01)

CORRECTION OF AGGREGATIVE FUNCTION OF THE TROMBOCYTES IN ARTERIAL HYPERTENSION PATIENTS WITH METABOLIC SYNDROM UNDER THE INFLUENCE OF SIMVASTATINE
Yazar:: N. J. Gromnazky, ve diğerleri
Baskı/Yayın Bilgisi: (2003-12-01)

The comorbid patients with arterial hypertension, chronic heart failure and chronic kidney disease: the role of fosinoprile
Yazar:: G. N. Gorokhovskaya, ve diğerleri
Baskı/Yayın Bilgisi: (2018-04-01)

Arterial hypertension and metabolic syndrome: specifics of antihypertensive therapy
Yazar:: L. I. Abasova, ve diğerleri
Baskı/Yayın Bilgisi: (2011-08-01)

Spirapril effects on heart remodeling in patients with mild to moderate arterial hypertension
Yazar:: M. M. Beraya, ve diğerleri
Baskı/Yayın Bilgisi: (2007-02-01)

Features of the clinical course of arterial hypertension in alien residents of Western Siberia with the establishment of patterns of metabolic changes
Yazar:: E. G. Ivanova, ve diğerleri
Baskı/Yayın Bilgisi: (2022-07-01)

The efficacy of available supplements and medical drugs in longevity medicine - a review
Yazar:: Michał Łata, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

Pathogenesis of arterial hypertension within the metabolic syndrome
Yazar:: A S Ryazanov, ve diğerleri
Baskı/Yayın Bilgisi: (2003-03-01)

Antihypertensive spirapril effectiveness in patients with mild to moderate arterial hypertension
Yazar:: M. M. Beraya, ve diğerleri
Baskı/Yayın Bilgisi: (1970-01-01)

Imidazoline receptor agonist moxonidine and arterial hypertension treatment in women with menopausal metabolic syndrome
Yazar:: E. V. Tishina, ve diğerleri
Baskı/Yayın Bilgisi: (2011-06-01)

Moxonidine for arterial hypertension treatment in menopausal women with metabolic syndrome
Yazar:: V. V. Trusov, ve diğerleri
Baskı/Yayın Bilgisi: (2007-08-01)

AFFECTIVE DISORDERS IN MEN WITH ARTERIAL HYPERTENSION IN COMBINATION WITH METABOLIC SYNDROME
Yazar:: Roman A. Yaskevich, ve diğerleri
Baskı/Yayın Bilgisi: (2022-08-01)

AFFECTIVE DISORDERS IN WOMEN WITH ARTERIAL HYPERTENSION IN COMBINATION WITH METABOLIC SYNDROME
Yazar:: Roman A. Yaskevich, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

SHIFTWORK AS ONE OF RISK FACTORS OF ARTERIAL HYPERTENSION AND METABOLIC DISORDERS
Yazar:: I. S. Dzherieva, ve diğerleri
Baskı/Yayın Bilgisi: (2015-12-01)